Manulife (Manufacturers Life Insurance)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$124M Sell
1,158,089
-26,826
-2% -$2.88M 0.11% 176
2025
Q1
$120M Buy
1,184,915
+14,766
+1% +$1.49M 0.11% 173
2024
Q4
$105M Buy
1,170,149
+49,683
+4% +$4.44M 0.09% 211
2024
Q3
$93.9M Buy
1,120,466
+20,330
+2% +$1.7M 0.08% 232
2024
Q2
$84.7M Buy
1,100,136
+54,206
+5% +$4.17M 0.08% 234
2024
Q1
$71.6M Sell
1,045,930
-58,155
-5% -$3.98M 0.07% 257
2023
Q4
$63.8M Buy
1,104,085
+19,999
+2% +$1.16M 0.04% 291
2023
Q3
$57.2M Buy
1,084,086
+14,825
+1% +$783K 0.03% 298
2023
Q2
$57.8M Sell
1,069,261
-2,603
-0.2% -$141K 0.03% 299
2023
Q1
$53.6M Buy
1,071,864
+16,563
+2% +$829K 0.03% 318
2022
Q4
$48.8M Sell
1,055,301
-22,486
-2% -$1.04M 0.03% 340
2022
Q3
$41.7M Sell
1,077,787
-9,431
-0.9% -$365K 0.03% 369
2022
Q2
$40.5M Sell
1,087,218
-45,412
-4% -$1.69M 0.03% 379
2022
Q1
$50.2M Sell
1,132,630
-503,168
-31% -$22.3M 0.03% 371
2021
Q4
$69.5K Buy
1,635,798
+273,082
+20% +$11.6K 0.04% 305
2021
Q3
$59.1M Sell
1,362,716
-422,364
-24% -$18.3M 0.05% 329
2021
Q2
$76.3M Sell
1,785,080
-249,381
-12% -$10.7M 0.06% 286
2021
Q1
$78.6M Sell
2,034,461
-306,797
-13% -$11.9M 0.07% 282
2020
Q4
$84.2M Buy
2,341,258
+795,892
+52% +$28.6M 0.08% 244
2020
Q3
$59M Sell
1,545,366
-10,585
-0.7% -$404K 0.06% 290
2020
Q2
$53.9M Buy
1,555,951
+5,816
+0.4% +$202K 0.05% 306
2020
Q1
$50.6M Sell
1,550,135
-15,258
-1% -$498K 0.06% 290
2019
Q4
$70.8M Buy
1,565,393
+185,471
+13% +$8.39M 0.07% 255
2019
Q3
$55.6M Sell
1,379,922
-368,208
-21% -$14.8M 0.06% 290
2019
Q2
$75.1M Buy
1,748,130
+376,572
+27% +$16.2M 0.09% 229
2019
Q1
$52.6M Buy
1,371,558
+4,847
+0.4% +$186K 0.06% 303
2018
Q4
$48.3M Sell
1,366,711
-27,857
-2% -$984K 0.06% 300
2018
Q3
$53.7M Sell
1,394,568
-166,920
-11% -$6.43M 0.06% 310
2018
Q2
$51.1M Sell
1,561,488
-528,335
-25% -$17.3M 0.06% 331
2018
Q1
$57.1M Buy
2,089,823
+21,360
+1% +$584K 0.06% 298
2017
Q4
$51.3M Buy
2,068,463
+12,031
+0.6% +$298K 0.06% 331
2017
Q3
$60M Buy
2,056,432
+69,606
+4% +$2.03M 0.07% 273
2017
Q2
$55.1M Sell
1,986,826
-406,405
-17% -$11.3M 0.07% 291
2017
Q1
$59.5M Buy
2,393,231
+958,828
+67% +$23.8M 0.08% 272
2016
Q4
$31M Sell
1,434,403
-195,487
-12% -$4.23M 0.04% 372
2016
Q3
$38.8M Sell
1,629,890
-57,462
-3% -$1.37M 0.06% 301
2016
Q2
$39.4M Buy
1,687,352
+12,842
+0.8% +$300K 0.06% 288
2016
Q1
$31.5M Buy
1,674,510
+348,566
+26% +$6.56M 0.03% 344
2015
Q4
$24.5K Sell
1,325,944
-66,354
-5% -$1.22K 0.02% 394
2015
Q3
$22.8K Buy
1,392,298
+40,784
+3% +$669 0.02% 423
2015
Q2
$23.9K Sell
1,351,514
-10,504
-0.8% -$186 0.03% 405
2015
Q1
$24.2K Sell
1,362,018
-33,597
-2% -$596 0.03% 396
2014
Q4
$18.5K Buy
1,395,615
+54,122
+4% +$717 0.03% 429
2014
Q3
$15.8K Sell
1,341,493
-5,075
-0.4% -$60 0.02% 468
2014
Q2
$17.2M Buy
1,346,568
+30,268
+2% +$387K 0.03% 439
2014
Q1
$17.8K Buy
1,316,300
+17,377
+1% +$235 0.03% 451
2013
Q4
$15.6K Sell
1,298,923
-164,102
-11% -$1.97K 0.02% 479
2013
Q3
$17.2K Buy
1,463,025
+38,106
+3% +$447 0.03% 442
2013
Q2
$13.2M Buy
+1,424,919
New +$13.2M 0.02% 469